HC-X027

N/A

Report date: 2023/12/07 16:44:32
NME

Base Information

Drug NameHC-X027
Drug Alias NameHC-X027
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsPrimary MyelofibrosisHematologic NeoplasmsTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHinova Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHinova Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPrimary MyelofibrosisHematologic NeoplasmsTriple Negative Breast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A